Why Now is a Great Time to Invest in Stocks

Day-to-day, stocks seem to flail around like lotto balls in a gravity-pick machine. Frenetic, directionless and wild. Over the long-term, however, stock prices are fueled by economic and earnings growth and behave rationally. Let’s examine the facts.

Unemployment is at a 50+ year low. Tech employment which comprises just under 4% of total U.S. jobs, is growing much faster than overall employment. This is good news for investors. Why? Because technological innovation increases worker productivity which then allows corporations to produce more goods per employee. And despite rising wages due to a scarcity of job seekers, improving productivity allows corporations to maintain profit margins and earnings growth – an important driver for stock prices.

Interest rates as measured by the1 -year Treasury have declined from almost 3.3% last fall to 2%. Lower interest rates can hurt savers but help spenders and boost the demand for housing. Low rates also make stocks more attractive. The legendary investor Bill Miller, in a recent interview with Barron’s, said that “stocks are ridiculously cheap” compared to bonds and cash. The market’s current price-to-earnings multiple of around 17x is above the historical average since WWII of 15x, but the average is distorted by periods of high-inflation, argues Miller. With low interest rates and low inflation, he would expect the multiple to be closer to 20x.

Read the full article at USA Today.

Don’t Stop Here

More To Explore

NMRA: Workforce Cuts Follow Failed Depression Trials

Company Overview Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company focused on neuroscience, recently thrust into the spotlight after a major late-stage trial setback.

CLDX: Strong Barzolvolimab Results Unveiled at EACCI!

Overview & Barzolvolimab Breakthrough Celldex Therapeutics (NASDAQ: CLDX) is a clinical-stage biotech focused on immunology, and it recently drew significant attention after unveiling compelling results